HUMAB

HuMab is developing SynThese™, a fully human antibody discovery transgenic mouse platform which harnesses HuMab's proprietary AiCE® technology... HuMab's vision is growing into a global biopharma company that focuses on developing innovative therapeutic interventions for patients with medical unmet needs by utilizing SynThese TM transgenic mouse platform, developed from our proprietary AiCE®(Artificial interspecies Chromosome Exchange) technology, and by establishing strategic alliances with global pharmaceuticals.